Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

4.880 +1.700 (+53.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 123,842,108
Open 4.030
Bid (Size) 4.960 (1)
Ask (Size) 5.000 (2)
Prev. Close 3.180
Today's Range 3.980 - 4.920
52wk Range 1.050 - 4.920
Shares Outstanding 64,465,037
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews
 
Via Benzinga

Performance

YTD
+163.8%
+163.8%
1 Month
+71.8%
+71.8%
3 Month
+99.2%
+99.2%
6 Month
+287.3%
+287.3%
1 Year
+138.0%
+138.0%

More News

Read More
Discover the most active stocks in Thursday's session.
Via Chartmill
What's Next: Taysha Gene Therapies's Earnings Preview
Via Benzinga
Where Taysha Gene Therapies Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Here are the top movers in Thursday's session.
Via Chartmill
Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy
Via Stocktwits
Which stocks are gapping on Thursday?
Via Chartmill
Top 2 Health Care Stocks That May Keep You Up At Night This Month
Via Benzinga
What's Driving the Market Sentiment Around Taysha Gene Therapies?
Via Benzinga
Is Taysha Gene Therapies Gaining or Losing Market Support?
Via Benzinga
A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts
Via Benzinga
Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock
Via Benzinga
Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data
Via Stocktwits
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 12, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
Via Chartmill
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 6 Analysts
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Earnings Scheduled For May 15, 2025
Via Benzinga
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Via Benzinga

Frequently Asked Questions

Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
The current price of Taysha Gene Therapies, Inc. - Common Stock is 4.880
When was Taysha Gene Therapies, Inc. - Common Stock last traded?
The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 10/02/25 04:00 PM ET
What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 314.59M
How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
Taysha Gene Therapies, Inc. - Common Stock has 315M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.